Mark Oldakowski - May 12, 2021 Form 4 Insider Report for Bionano Genomics, Inc (BNGO)

Role
Chief Operating Officer
Signature
/s/ R. Erik Holmlin, Attorney-in-Fact
Stock symbol
BNGO
Transactions as of
May 12, 2021
Transactions value $
$0
Form type
4
Date filed
5/14/2021, 07:15 PM
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Award $0 +240K +1985.77% $0.00 252K May 12, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
F2 Includes: 495 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on December 10, 2018, 1,021 shares acquired under the ESPP on June 10, 2019, 1,405 shares acquired under the ESPP on December 10, 2019, 1,199 shares acquired under the ESPP on June 10, 2020 and 1,151 shares acquired under the ESPP on December 10, 2020.